Article
Low-dose Aspirin Use to Prevent Colorectal Cancer and Cardiovascular Disease
Gastroenterology Nursing
Document Type
Peer-Reviewed Article
Publication Date
1-1-2023
Disciplines
Abstract
The American Cancer Society (ACS) estimates 151,030 new cases and 52,580 deaths from colorectal cancer (CRC) in 2022.
The gastroenterology nurse sees many patients for CRC screening and a variety of gastroenteric conditions. This population may have been started on low-dose aspirin for CVD prevention or CRC chemoprevention. The updated and more restricted USPSTF (2022) recommendations should be used to guide their treatment.
DOI
10.1097/SGA.0000000000000680
PMID
36624567
Publisher
Wolters Kluwer
Citation Information
Morrow, L., & Greenwald, B. (2023). Low-dose aspirin use to prevent colorectal cancer and cardiovascular disease. Gastroenterology Nursing, 46(1), 76-77. Doi.org/10.1097/SGA.0000000000000680